Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines

Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry...

Descripción completa

Detalles Bibliográficos
Autores principales: Woode, Denzel R., Aiyer, Harini S., Sie, Nicole, Zwart, Alan L., Li, Liya, Seeram, Navindra P., Clarke, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549366/
https://www.ncbi.nlm.nih.gov/pubmed/23346406
http://dx.doi.org/10.1155/2012/147828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549366/
https://www.ncbi.nlm.nih.gov/pubmed/23346406
http://dx.doi.org/10.1155/2012/147828

Ejemplares similares